2-pyrones

US10188592B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10188592-B2
Application numberUS-201615282317-A
CountryUS
Kind codeB2
Filing dateSep 30, 2016
Priority dateDec 10, 2010
Publication dateJan 29, 2019
Grant dateJan 29, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to the use of compounds of the formula (I) for the care, preservation or improvement of the general condition or appearance of the skin or hair, and to preparations comprising compounds of the formula (I).

First claim

Opening claim text (preview).

The invention claimed is: 1. A cosmetic or pharmaceutical composition comprising at least one compound of the formula (I) where R1 stands for a straight-chain or branched C 1 - to C 20 -alkyl group, R2 stands for H or straight-chain or branched C 1 - to C 20 -alkyl group, R4 stands for H, straight-chain or branched C 1 - to C 20 -alkyl group or straight-chain or branched C 2 - to C 20 -alkenyl group having one or more double bonds, R3 stands for a radical selected from H, straight-chain or branched C 2 - to C 20 -alkyl group, straight-chain or branched C 2 - to C 20 -alkenyl group having one or more double bonds, where the alkenyl group may also be substituted by one or more saturated or unsaturated C 3 - to C 12 -cycloalkyl groups, straight-chain or branched C 2 - to C 20 -alkynyl group having one or more triple bonds, saturated or partially unsaturated non-aromatic C 3 - to C 12 -cycloalkyl group, where the rings may in each case also be bridged by —(CH 2 ) n — groups where n=1 to 3, an acyl radical of the formula —C(═O)—R6, R6 stands for straight-chain or branched C 1 - to C 20 -alkyl group, a radical of the formula (II) in which X stands for straight-chain or branched C 1 - to C 6 -alkylene or straight-chain or branched C 2 - to C 6 -alkenylene and the radicals R5 are selected, independently of one another, from H, OH, straight-chain or branched C 1 - to C 6 -alkyl or straight-chain or branched O—(C 1 - to C 6 -alkyl), at least one vehicle which is suitable for a topical application, and a further anti-ageing or anti-cellulite active compound; with the proviso that R4 is a straight-chain or branched C 2 - to C 20 -alkenyl group having one or more double bonds or R3 is a straight-chain or branched C 2 - to C 20 -alkenyl group having one or more double bonds, where the alkenyl group may also be substituted by one or more saturated or unsaturated C 3 - to C 12 -cycloalkyl groups, straight-chain or branched C 2 - to C 20 -alkynyl group having one or more triple bonds, saturated or partially unsaturated non-aromatic C 3 - to C 12 -cycloalkyl group, where the rings may in each case also be bridged by —(CH 2 ) n — groups where n=1 to 3, or an acyl radical of the formula —C(═O)—R6. 2. A composition according to claim 1 , wherein the at least one compound of the formula (I) is present in an amount of 0.01 to 20% by weight. 3. A process for the preparation of a composition according to claim 1 , which comprises mixing the compound of the formula (I) with a vehicle which is suitable for a topical application. 4. A composition according to claim 1 , wherein, in formula (I), R1 stands for a straight-chain or branched C 1 - to C 6 -alkyl group. 5. A composition according to claim 1 , wherein, in formula (I), R2 stands for H or a straight-chain or branched C 1 - to C 6 -alkyl group. 6. A composition according to claim 1 , wherein, in formula (I), R4 stands for H or a straight-chain or branched C 2 - to C 20 -alkenyl group having one or more double bonds. 7. A composition according to claim 1 , wherein, in formula (I), R3 stands for a radical selected from H, straight-chain or branched C 2 - to C 20 -alkyl group, straight-chain or branched C 2 - to C 20 -alkenyl group having one or more double bonds, where the alkenyl group may also be substituted by one or more saturated or partially unsaturated non-aromatic cyclohexyl groups, or an acyl radical of the formula —C(═O)—R6. 8. A composition according to claim 1 , wherein, in formula (I), the radicals R5 are selected, independently of one another, from H, OH or straight-chain or branched O—(C 1 - to C 6 -alkyl). 9. A composition according to claim 1 , wherein, the compound of the formula (I) is selected from the compounds of formulae (Id) to (Ii): 10. A composition according to claim 1 , wherein, in formula (I), the radical R3 stands for a radical selected from straight-chain or branched C 2 - to C 20 -alkenyl group having one or more double bonds, where the alkenyl group may also be substituted by one or more saturated or unsaturated C 3 - to C 12 -cycloalkyl groups, straight-chain or branched C 2 - to C 20 -alkynyl group having one or more triple bonds, saturated or partially unsaturated non-aromatic C 3 - to C 12 -cycloalkyl group, where the rings may in each case also be bridged by —(CH 2 ) n — groups where n=1 to 3, or an acyl radical of the formula —C(═O)—R6. 11. A compound of one of the formula (Id) to (Ii) 12. A composition according to claim 2 , wherein, the compound of the formula (I) is selected from the compounds of the formula (Id) to (Ii):

Assignees

Inventors

Classifications

  • Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14) · CPC title

  • specific for leukemia · CPC title

  • for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis · CPC title

  • Antineoplastic agents · CPC title

  • Drugs for disorders of the cardiovascular system · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10188592B2 cover?
The present invention relates to the use of compounds of the formula (I) for the care, preservation or improvement of the general condition or appearance of the skin or hair, and to preparations comprising compounds of the formula (I).
Who is the assignee on this patent?
Merck Patent Gmbh
What technology area does this patent fall under?
Primary CPC classification A61K8/498. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).